loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X

Information, Expiry & Status of FDA Orange Book Patents covering Sapropterin Dihydrochloride

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BIOMARIN PHARM (42)

filter

01 7566462 (1)

02 7566462*PED (1)

03 7566714 (3)

04 7566714*PED (3)

05 7612073 (3)

06 7612073*PED (3)

07 7727987 (1)

08 7727987*PED (1)

09 8003126 (1)

10 8003126*PED (1)

11 8067416 (3)

12 8067416*PED (3)

13 8318745 (1)

14 8318745*PED (1)

15 9216178 (2)

16 9216178*PED (2)

17 9433624 (3)

18 9433624*PED (3)

19 RE43797 (3)

20 RE43797*PED (3)

filter

01 Blank (42)

filter

01 Y (5)

02 Blank (37)

filter

01 2024-11-17 (17)

02 2025-05-17 (17)

03 2025-11-16 (2)

04 2026-05-16 (2)

05 2032-11-01 (2)

06 2033-05-01 (2)

URL Supplier Web Content
8067416
2024-11-17
U-1589
205065
METHOD OF USE FOR REDUCING BLOOD PHENYLALANINE LEVELS IN A HUMAN SUFFERING FROM HYPERPHENYLALANINEMIA
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7566714
2024-11-17
U-1589
205065
METHOD OF USE FOR REDUCING BLOOD PHENYLALANINE LEVELS IN A HUMAN SUFFERING FROM HYPERPHENYLALANINEMIA
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
RE43797
2024-11-17
U-1156
22181
TO REDUCE BLOOD PHENYLALANINE (PHE) LEVELS IN PATINETS WITH HYPERPHENYLALANINEMIA (HPA)
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7566714
2024-11-17
U-1589
205065
METHOD OF USE FOR REDUCING BLOOD PHENYLALANINE LEVELS IN A HUMAN SUFFERING FROM HYPERPHENYLALANINEMIA
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
RE43797
2024-11-17
U-1590
205065
KUVAN IS INDICATED TO REDUCE BLOOD PHENYLALANINE LEVELS IN PATIENTS WITH HYPERPHENYLALANINEMIA
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7566714
2024-11-17
U-989
22181
FOR REDUCING BLOOD PHENYLALANINE LEVELS IN A HUMAN SUFFERING FROM HYPERPHENYLALANINEMIA
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
RE43797
2024-11-17
U-1590
205065
KUVAN IS INDICATED TO REDUCE BLOOD PHENYLALANINE LEVELS IN PATIENTS WITH HYPERPHENYLALANINEMIA
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9433624
2024-11-17
U-1589
205065
METHOD OF USE FOR REDUCING BLOOD PHENYLALANINE LEVELS IN A HUMAN SUFFERING FROM HYPERPHENYLALANINEMIA
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7612073
2024-11-17
U-1010
205065
TO REDUCE BLOOD PHENYLALANINE LEVELS IN PATIENTS WITH HYPERPHENYLALANINEMIA DUE TO TETRA HYDROBIOPTERIN RESPONSIVE PHENYLKETONURIA. KUVAN SHOULD BE TA
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9433624
2024-11-17
U-1589
205065
METHOD OF USE FOR REDUCING BLOOD PHENYLALANINE LEVELS IN A HUMAN SUFFERING FROM HYPERPHENYLALANINEMIA
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY